Judah Frommer
Stock Analyst at Morgan Stanley
(3.99)
# 1,908
Out of 4,547 analysts
454
Total ratings
55.5%
Success rate
5.2%
Average return
Main Sectors:
Stocks Rated by Judah Frommer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLDX Celldex Therapeutics | Maintained: Buy | $44 → $40 | $35.66 | +12.17% | 10 | Jul 22, 2026 | |
| TRVI Trevi Therapeutics | Maintained: Buy | $20 | $18.18 | +10.01% | 6 | Jul 17, 2026 | |
| KLRS Kalaris Therapeutics | Maintained: Buy | $14 | $4.04 | +246.53% | 3 | Jul 17, 2026 | |
| INCY Incyte | Maintained: Hold | $103 | $117.39 | -12.26% | 12 | Jul 13, 2026 | |
| LKFT Lakefront Biotherapeutics NV | Initiated Coverage: Hold | $22 → $30 | $29.23 | +2.63% | 51 | Jul 10, 2026 | |
| CMPS COMPASS Pathways | Maintained: Buy | $17 | $12.18 | +39.57% | 5 | Jul 7, 2026 | |
| FDMT 4D Molecular Therapeutics | Maintained: Hold | n/a | $11.38 | - | 13 | Jun 29, 2026 | |
| EVMN Evommune | Maintained: Buy | $55 → $26 | $12.22 | +112.77% | 8 | Jun 29, 2026 | |
| KYMR Kymera Therapeutics | Maintained: Buy | $119 | $113.37 | +4.97% | 11 | Jun 25, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $16 | $10.34 | +54.74% | 20 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $1.93 | - | 9 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $29.03 | +82.57% | 2 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 → $132 | $134.09 | -1.56% | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $3 | $1.60 | +88.09% | 14 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $11 | $11.64 | -9.36% | 4 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $22 | $32.36 | -32.01% | 11 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $37 | $28.15 | +31.44% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $92 → $94 | $78.50 | +19.75% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $33 | $28.37 | +16.34% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $34 | $28.26 | +20.31% | 6 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $9.57 | +108.99% | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $191 → $201 | $161.08 | +24.78% | 2 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $141 → $139 | $16.21 | n/a | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $138 | $0.0005 | n/a | 9 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $6.00 | n/a | 8 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.77 | n/a | 8 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $7.14 | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $28.81 | n/a | 7 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $22 | $32.34 | n/a | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $10.22 | n/a | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $13 | $2.23 | n/a | 4 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $11 → $8 | $3.68 | n/a | 9 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $55 | $40.09 | n/a | 6 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $46 | $108.62 | n/a | 3 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $3.5 | $18.78 | n/a | 1 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $24 | $94.75 | n/a | 7 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $26 | $74.69 | n/a | 10 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $14.72 | n/a | 2 | Jul 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $90 → $95 | $66.00 | n/a | 10 | Jul 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $328 | $929.22 | n/a | 6 | Jul 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 | $57.78 | n/a | 28 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 → $116 | $203.71 | n/a | 9 | Jun 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €22.00 → €24.00 | €35.86 | n/a | 3 | Jun 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $98 → $107 | $125.74 | n/a | 19 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $154 → $178 | $123.20 | n/a | 10 | May 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $38 | $92.34 | n/a | 4 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $63 | $81.22 | n/a | 17 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $110.34 | n/a | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $19.45 | n/a | 1 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $40.70 | n/a | 1 | Mar 6, 2019 |
Celldex Therapeutics
Jul 22, 2026
Maintained: Buy
Price Target: $44 → $40
Current: $35.66
Upside: +12.17%
Trevi Therapeutics
Jul 17, 2026
Maintained: Buy
Price Target: $20
Current: $18.18
Upside: +10.01%
Kalaris Therapeutics
Jul 17, 2026
Maintained: Buy
Price Target: $14
Current: $4.04
Upside: +246.53%
Incyte
Jul 13, 2026
Maintained: Hold
Price Target: $103
Current: $117.39
Upside: -12.26%
Lakefront Biotherapeutics NV
Jul 10, 2026
Initiated Coverage: Hold
Price Target: $22 → $30
Current: $29.23
Upside: +2.63%
COMPASS Pathways
Jul 7, 2026
Maintained: Buy
Price Target: $17
Current: $12.18
Upside: +39.57%
4D Molecular Therapeutics
Jun 29, 2026
Maintained: Hold
Price Target: n/a
Current: $11.38
Upside: -
Evommune
Jun 29, 2026
Maintained: Buy
Price Target: $55 → $26
Current: $12.22
Upside: +112.77%
Kymera Therapeutics
Jun 25, 2026
Maintained: Buy
Price Target: $119
Current: $113.37
Upside: +4.97%
REGENXBIO
Jun 24, 2026
Maintained: Buy
Price Target: $16
Current: $10.34
Upside: +54.74%
Jun 18, 2026
Downgraded: Sell
Price Target: n/a
Current: $1.93
Upside: -
Jun 3, 2026
Maintained: Buy
Price Target: $53
Current: $29.03
Upside: +82.57%
Jun 2, 2026
Rated: Buy
Price Target: $145 → $132
Current: $134.09
Upside: -1.56%
May 18, 2026
Rated: Hold
Price Target: $3
Current: $1.60
Upside: +88.09%
May 18, 2026
Maintained: Buy
Price Target: $28 → $11
Current: $11.64
Upside: -9.36%
May 14, 2026
Maintained: Hold
Price Target: $21 → $22
Current: $32.36
Upside: -32.01%
May 12, 2026
Rated: Buy
Price Target: $36 → $37
Current: $28.15
Upside: +31.44%
May 8, 2026
Maintained: Buy
Price Target: $92 → $94
Current: $78.50
Upside: +19.75%
May 8, 2026
Maintained: Hold
Price Target: $34 → $33
Current: $28.37
Upside: +16.34%
May 7, 2026
Maintained: Buy
Price Target: $35 → $34
Current: $28.26
Upside: +20.31%
Mar 26, 2026
Rated: Buy
Price Target: $20
Current: $9.57
Upside: +108.99%
Mar 3, 2026
Maintained: Buy
Price Target: $191 → $201
Current: $161.08
Upside: +24.78%
Aug 3, 2023
Maintained: Hold
Price Target: $141 → $139
Current: $16.21
Upside: n/a
Jun 5, 2023
Maintained: Buy
Price Target: $138
Current: $0.0005
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $13
Current: $6.00
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $40
Current: $0.77
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $9
Current: $7.14
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $28
Current: $28.81
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $21 → $22
Current: $32.34
Upside: n/a
Mar 31, 2023
Maintained: Buy
Price Target: $8 → $7
Current: $10.22
Upside: n/a
Mar 28, 2023
Maintained: Buy
Price Target: $16 → $13
Current: $2.23
Upside: n/a
Mar 9, 2023
Downgraded: Hold
Price Target: $11 → $8
Current: $3.68
Upside: n/a
Feb 28, 2023
Maintained: Buy
Price Target: $51 → $55
Current: $40.09
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $57 → $46
Current: $108.62
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: $3.5
Current: $18.78
Upside: n/a
Aug 4, 2020
Maintained: Buy
Price Target: $23 → $24
Current: $94.75
Upside: n/a
Jul 30, 2020
Maintained: Hold
Price Target: $22 → $26
Current: $74.69
Upside: n/a
Jul 27, 2020
Maintained: Buy
Price Target: $18
Current: $14.72
Upside: n/a
Jul 22, 2020
Rated: Hold
Price Target: $90 → $95
Current: $66.00
Upside: n/a
Jul 8, 2020
Maintained: Hold
Price Target: $328
Current: $929.22
Upside: n/a
Jun 18, 2020
Maintained: Hold
Price Target: $35
Current: $57.78
Upside: n/a
Jun 10, 2020
Rated: Buy
Price Target: $125 → $116
Current: $203.71
Upside: n/a
Jun 3, 2020
Maintained: Hold
Price Target: €22.00 → €24.00
Current: €35.86
Upside: n/a
May 28, 2020
Rated: Buy
Price Target: $98 → $107
Current: $125.74
Upside: n/a
May 22, 2020
Maintained: Hold
Price Target: $154 → $178
Current: $123.20
Upside: n/a
May 21, 2020
Rated: Buy
Price Target: $31 → $38
Current: $92.34
Upside: n/a
May 5, 2020
Rated: Buy
Price Target: $67 → $63
Current: $81.22
Upside: n/a
May 4, 2020
Maintained: Buy
Price Target: $39
Current: $110.34
Upside: n/a
Mar 6, 2020
Downgraded: Hold
Price Target: n/a
Current: $19.45
Upside: n/a
Mar 6, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $40.70
Upside: n/a